JP2009516518A5 - - Google Patents

Download PDF

Info

Publication number
JP2009516518A5
JP2009516518A5 JP2008541543A JP2008541543A JP2009516518A5 JP 2009516518 A5 JP2009516518 A5 JP 2009516518A5 JP 2008541543 A JP2008541543 A JP 2008541543A JP 2008541543 A JP2008541543 A JP 2008541543A JP 2009516518 A5 JP2009516518 A5 JP 2009516518A5
Authority
JP
Japan
Prior art keywords
rna molecules
specificity
regulate
expression
manufactured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2008541543A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009516518A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2006/001750 external-priority patent/WO2007056829A1/en
Publication of JP2009516518A publication Critical patent/JP2009516518A/ja
Publication of JP2009516518A5 publication Critical patent/JP2009516518A5/ja
Ceased legal-status Critical Current

Links

JP2008541543A 2005-11-21 2006-11-21 ２種の活性鎖を有する多標的干渉ｒｎａならびにそれらの設計および使用方法 Ceased JP2009516518A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73844105P 2005-11-21 2005-11-21
US73864005P 2005-11-21 2005-11-21
PCT/AU2006/001750 WO2007056829A1 (en) 2005-11-21 2006-11-21 Multitargeting interfering rnas having two active strands and methods for their design and use

Publications (2)

Publication Number Publication Date
JP2009516518A JP2009516518A (ja) 2009-04-23
JP2009516518A5 true JP2009516518A5 (cg-RX-API-DMAC7.html) 2012-07-26

Family

ID=38048226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008541543A Ceased JP2009516518A (ja) 2005-11-21 2006-11-21 ２種の活性鎖を有する多標的干渉ｒｎａならびにそれらの設計および使用方法
JP2008541541A Expired - Fee Related JP5078904B2 (ja) 2005-11-21 2006-11-21 多標的干渉ｒｎａならびにそれらの使用および設計方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008541541A Expired - Fee Related JP5078904B2 (ja) 2005-11-21 2006-11-21 多標的干渉ｒｎａならびにそれらの使用および設計方法

Country Status (6)

Country Link
US (3) US20070269815A1 (cg-RX-API-DMAC7.html)
EP (2) EP1951736A4 (cg-RX-API-DMAC7.html)
JP (2) JP2009516518A (cg-RX-API-DMAC7.html)
AU (2) AU2006315099C1 (cg-RX-API-DMAC7.html)
CA (2) CA2630952A1 (cg-RX-API-DMAC7.html)
WO (2) WO2007056829A1 (cg-RX-API-DMAC7.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053019A2 (en) * 2006-11-02 2008-05-08 Dsm Ip Assets B.V. Method for reducing the expression of a gene in a filamentous fungal cell
US20120071539A1 (en) * 2006-12-12 2012-03-22 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2008094516A2 (en) 2007-01-29 2008-08-07 City Of Hope Multi-targeting short interfering rnas
EP2468864A1 (en) * 2007-03-02 2012-06-27 Marina Biotech, Inc. Nucleic acid compounds for inhibiting VEGF family gene expression and uses thereof
JP2010519906A (ja) * 2007-03-02 2010-06-10 エムディーアールエヌエー，インコーポレイテッド Ｅｒｂｂファミリー遺伝子の発現を抑制するための核酸化合物およびその使用
US20080311040A1 (en) * 2007-03-06 2008-12-18 Flagship Ventures METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
US8378088B2 (en) 2007-05-03 2013-02-19 Merck Sharp & Dohme Corp. Compositions comprising MIR34 therapeutic agents for treating cancer
AU2008251037A1 (en) * 2007-05-15 2008-11-20 Johnson & Johnson Research Pty Limited Suppression of viruses involved in respiratory infection or disease
US20100022618A1 (en) * 2007-09-05 2010-01-28 Dong Liang Long interfering nucleic acid duplexes targeting multiple RNA targets
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
MX2010005166A (es) 2007-11-09 2010-10-07 Univ Texas Micro arn de la familia mir-15 que modulan la sobrevivencia de cardiomiocitos y reparacion cardiaca.
GB2468477A (en) * 2009-03-02 2010-09-15 Mina Therapeutics Ltd Double stranded RNA molecule comprising siRNA and miRNA precursors
EP2440666B1 (en) 2009-06-10 2017-03-01 Temasek Life Sciences Laboratory Limited Virus induced gene silencing (vigs) for functional analysis of genes in cotton
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
US20130023578A1 (en) * 2009-12-31 2013-01-24 Samyang Biopharmaceuticals Corporation siRNA for inhibition of c-Met expression and anticancer composition containing the same
NZ601784A (en) 2010-03-08 2014-08-29 Monsanto Technology Llc Polynucleotide molecules for gene regulation in plants
AR083445A1 (es) 2010-10-14 2013-02-27 Univ Mie siARN CONTRA LA FIBROSIS
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
WO2013040057A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
US9580708B2 (en) 2011-09-14 2017-02-28 Rana Therapeutics, Inc. Multimeric oligonucleotides compounds
AU2012358238B2 (en) * 2011-12-22 2017-12-07 C. Frank Bennett Methods for modulating Metastasis-Associated-in-Lung-Adenocarcinoma-Transcript-1(MALAT-1) expression
US9212363B2 (en) * 2012-05-11 2015-12-15 City Of Hope RNAI molecules with non-watson crick pairing based on artificial mutation consensus sequences to counter escape mutations
US10837014B2 (en) 2012-05-16 2020-11-17 Translate Bio Ma, Inc. Compositions and methods for modulating SMN gene family expression
EP2850185A4 (en) 2012-05-16 2015-12-30 Rana Therapeutics Inc COMPOSITIONS AND METHOD FOR MODULATING UTRN GENE EXPRESSION
CN104583401A (zh) 2012-05-16 2015-04-29 Rana医疗有限公司 用于调节atp2a2表达的组合物和方法
CA2873779A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics Inc. Compositions and methods for modulating mecp2 expression
KR20150030205A (ko) 2012-05-16 2015-03-19 라나 테라퓨틱스, 인크. Smn 유전자 패밀리 발현을 조절하기 위한 조성물 및 방법
BR112014028631A2 (pt) 2012-05-16 2017-10-17 Rana Therapeutics Inc composições e métodos para modulação da expressão da família de genes da hemoglobina
EP2855680B8 (en) 2012-05-24 2020-04-15 Monsanto Technology LLC Compositions and methods for silencing gene expression
US9163235B2 (en) 2012-06-21 2015-10-20 MiRagen Therapeutics, Inc. Inhibitors of the miR-15 family of micro-RNAs
EP2895200B1 (en) 2012-09-14 2019-11-06 Translate Bio MA, Inc. Multimeric oligonucleotide compounds
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
US10000753B2 (en) * 2013-01-08 2018-06-19 Benitec Biopharma Limited Age-related macular degeneration treatment
EP2971185A4 (en) 2013-03-13 2017-03-08 Monsanto Technology LLC Methods and compositions for weed control
BR112015022797A2 (pt) 2013-03-13 2017-11-07 Monsanto Technology Llc método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
MX359191B (es) 2013-07-19 2018-09-18 Monsanto Technology Llc Composiciones y métodos para controlar leptinotarsa.
US10174328B2 (en) 2013-10-04 2019-01-08 Translate Bio Ma, Inc. Compositions and methods for treating amyotrophic lateral sclerosis
UA120426C2 (uk) 2013-11-04 2019-12-10 Монсанто Текнолоджі Елелсі Композиція та спосіб для боротьби з членистоногими паразитами та зараженням шкідниками
UA119253C2 (uk) 2013-12-10 2019-05-27 Біолоджикс, Інк. Спосіб боротьби із вірусом у кліща varroa та у бджіл
BR112016016337A2 (pt) 2014-01-15 2017-10-03 Monsanto Technology Llc Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps
EP3122365B1 (en) 2014-03-25 2023-05-03 Arcturus Therapeutics, Inc. Transthyretin allele selective una oligomers for gene silencing
US9856475B2 (en) 2014-03-25 2018-01-02 Arcturus Therapeutics, Inc. Formulations for treating amyloidosis
CN106460025A (zh) 2014-03-25 2017-02-22 阿克丘勒斯治疗公司 在基因沉默中具有降低的脱靶效应的una寡聚物
CN110506752B (zh) 2014-04-01 2022-02-18 孟山都技术公司 用于控制虫害的组合物和方法
EP3158067B1 (en) * 2014-06-23 2020-08-12 Monsanto Technology LLC Compositions and methods for regulating gene expression via rna interference
WO2015200539A1 (en) 2014-06-25 2015-12-30 Monsanto Technology Llc Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
US10378012B2 (en) 2014-07-29 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling insect pests
EP3235906B1 (en) 2014-12-15 2021-06-23 Bonac Corporation Single-stranded nucleic acid molecule for inhibiting tgf- beta 1 expression
UA124255C2 (uk) 2015-01-22 2021-08-18 Монсанто Текнолоджі Елелсі Інсектицидна композиція та спосіб боротьби з leptinotarsa
EP3277289A4 (en) 2015-04-01 2018-12-05 Arcturus Therapeutics, Inc. Therapeutic una oligomers and uses thereof
UY36703A (es) 2015-06-02 2016-12-30 Monsanto Technology Llc Composiciones y métodos para la administración de un polinucleótido en una planta
AU2016270913A1 (en) 2015-06-03 2018-01-04 Monsanto Technology Llc Methods and compositions for introducing nucleic acids into plants
WO2017015671A1 (en) 2015-07-23 2017-01-26 Arcturus Therapeutics, Inc. Compositions for treating amyloidosis
WO2017032776A1 (en) * 2015-08-21 2017-03-02 Universitätsklinikum Jena Human micrornas for treatment of malignant tumours
CA3061721A1 (en) * 2017-05-01 2018-11-08 Donald Danforth Plant Science Center Rnai approach for crop pest protection
JP7492526B2 (ja) 2019-02-27 2024-05-29 アイオーニス ファーマシューティカルズ， インコーポレーテッド Ｍａｌａｔ１発現のモジュレーター
KR20240024172A (ko) * 2021-06-23 2024-02-23 베르사멥 아게 유전자의 발현을 조절하기 위한 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050048529A1 (en) * 2002-02-20 2005-03-03 Sirna Therapeutics, Inc. RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
US20050187174A1 (en) * 2001-05-18 2005-08-25 Sirna Therapeutics, Inc. RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
AU2004266311B2 (en) * 2001-05-18 2009-07-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2003070912A2 (en) * 2001-06-06 2003-08-28 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US20050148530A1 (en) * 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050209180A1 (en) * 2001-05-18 2005-09-22 Sirna Therapeutics, Inc. RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
KR100774041B1 (ko) * 2003-01-17 2007-11-06 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 소간섭 ｒｎａ 유전자 치료
US7893034B2 (en) * 2004-09-02 2011-02-22 Yale University Regulation of oncogenes by microRNAs

Similar Documents

Publication Publication Date Title
JP2009516518A5 (cg-RX-API-DMAC7.html)
JP2009516517A5 (cg-RX-API-DMAC7.html)
EP1941050A4 (en) METHODS AND COMPOSITIONS FOR PRODUCING SINGLE-SEQUENCE DNA PROBES, DNA-PROBE LABELING AND USE THEREOF
EP2268813A4 (en) RNA MOLECULES AND USES THEREOF
EP1943348A4 (en) COMPOSITIONS, METHODS AND KITS FOR THE AMPLIFICATION OF NUCLEIC ACIDS
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
WO2006135684A3 (en) Methods and kits for sense rna synthesis
DE602006008827D1 (de) Herbizidresistenz verleihende gene grg23 und grg51
EP2037737A4 (en) PROTEINS, NUCLEIC ACIDS FOR THEIR CODING AND CORRESPONDING USES.
WO2010009478A3 (en) Compositions and methods for treating disorders associated with overweight animals
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
ZA200900494B (en) DNA Molecules and methods
PL1751278T3 (pl) Cząsteczki kwasu nukleinowego Nicotiana i ich zastosowanie
WO2008030996A3 (en) Sirna and methods of manufacture
IL201445A0 (en) Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
WO2007120955A3 (en) Genes affecting human memory performance
WO2007149521A3 (en) Nucleotide motifs providing localization elements and methods of use
WO2009089277A3 (en) Rel inhibitors and methods of use thereof
DE112006003704A5 (de) DNA-Konstrukte zur spezifischen Hemmung der Genexpression durch RNA-Interferenz
EP2121921A4 (en) NEW, STRESSTOLERANZ TRANSMITTING GENES AND RNA MOLECULES
WO2009039300A8 (en) Compositions comprising hif-1 alpha sirna and methods of use thereof
EP2084283A4 (en) DNA MUTANT POLYMERASES AND THEIR GENES
JP2009511076A5 (cg-RX-API-DMAC7.html)
EP2320931A4 (en) COMPOSITIONS WITH MG29 NUCLEIC ACIDS, POLYPEPTIDES AND RELEVANT METHOD OF USE